Principal Investigator
Henry Moore
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20221210
Clinical Trial Summary
A PHASE 3, MULTICENTER, OPEN-LABEL SAFETY
STUDY TO EVALUATE THE LONG-TERM SAFETY
AND TOLERABILITY OF SAGE-718 IN PARTICIPANTS
WITH HUNTINGTON’S DISEASE
Phase
TBD
Funding Agency/Sponsor
Other
Disease
Other
Contact Information
Study Contact
Wilfredo Rodriguez Somoza
Phone Number
+1 (561) 9394169
Email
wxr205@miami.edu